118 related articles for article (PubMed ID: 38717443)
1. Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis.
Unterman A; Zhao AY; Neumark N; Schupp JC; Ahangari F; Cosme C; Sharma P; Flint J; Stein Y; Ryu C; Ishikawa G; Sumida TS; Gomez JL; Herazo-Maya JD; Dela Cruz CS; Herzog EL; Kaminski N
Am J Respir Crit Care Med; 2024 May; ():. PubMed ID: 38717443
[TBL] [Abstract][Full Text] [Related]
2. Single-cell profiling reveals immune aberrations in progressive idiopathic pulmonary fibrosis.
Unterman A; Zhao AY; Neumark N; Schupp JC; Ahangari F; Cosme C; Sharma P; Flint J; Stein Y; Ryu C; Ishikawa G; Sumida TS; Gomez JL; Herazo-Maya J; Dela Cruz CS; Herzog EL; Kaminski N
medRxiv; 2023 Apr; ():. PubMed ID: 37163015
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Blood Single-Cell Sequencing Uncovers Common and Specific Immune Aberrations in Fibrotic Lung Diseases.
Zhao AY; Unterman A; Abu Hussein N; Sharma P; Flint J; Yan X; Adams TS; Justet A; Sumida TS; Zhao J; Schupp JC; Raredon MSB; Ahangari F; Zhang Y; Buendia-Roldan I; Adegunsoye A; Sperling AI; Prasse A; Ryu C; Herzog E; Selman M; Pardo A; Kaminski N
bioRxiv; 2023 Sep; ():. PubMed ID: 37786685
[TBL] [Abstract][Full Text] [Related]
4. Increased activated regulatory T cells proportion correlate with the severity of idiopathic pulmonary fibrosis.
Hou Z; Ye Q; Qiu M; Hao Y; Han J; Zeng H
Respir Res; 2017 Sep; 18(1):170. PubMed ID: 28886713
[TBL] [Abstract][Full Text] [Related]
5. Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis.
Kotsianidis I; Nakou E; Bouchliou I; Tzouvelekis A; Spanoudakis E; Steiropoulos P; Sotiriou I; Aidinis V; Margaritis D; Tsatalas C; Bouros D
Am J Respir Crit Care Med; 2009 Jun; 179(12):1121-30. PubMed ID: 19342412
[TBL] [Abstract][Full Text] [Related]
6. Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune Phenotype.
Fraser E; Denney L; Antanaviciute A; Blirando K; Vuppusetty C; Zheng Y; Repapi E; Iotchkova V; Taylor S; Ashley N; St Noble V; Benamore R; Hoyles R; Clelland C; Rastrick JMD; Hardman CS; Alham NK; Rigby RE; Simmons A; Rehwinkel J; Ho LP
Front Immunol; 2021; 12():623430. PubMed ID: 33746960
[TBL] [Abstract][Full Text] [Related]
7. Expansion of distinct peripheral blood myeloid cell subpopulations in patients with rheumatoid arthritis-associated interstitial lung disease.
Poole JA; Cole KE; Thiele GM; Talmadge JE; England BR; Nelson AJ; Gleason A; Schwab A; Gaurav R; Duryee MJ; Bailey KL; Romberger DJ; Hershberger D; De Graaff JV; May SM; Walenz R; Kramer B; Mikuls TR
Int Immunopharmacol; 2024 Jan; 127():111330. PubMed ID: 38086271
[TBL] [Abstract][Full Text] [Related]
8. Genetic Variation in CCL18 Gene Influences CCL18 Expression and Correlates with Survival in Idiopathic Pulmonary Fibrosis: Part A.
Wiertz IA; Moll SA; Seeliger B; Barlo NP; van der Vis JJ; Korthagen NM; Rijkers GT; Ruven HJT; Grutters JC; Prasse A; van Moorsel CHM
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575869
[TBL] [Abstract][Full Text] [Related]
9. Skewed Lung CCR4 to CCR6 CD4
Adegunsoye A; Hrusch CL; Bonham CA; Jaffery MR; Blaine KM; Sullivan M; Churpek MM; Strek ME; Noth I; Sperling AI
Front Immunol; 2016; 7():516. PubMed ID: 27933058
[TBL] [Abstract][Full Text] [Related]
10. Proportions of resting memory T cells and monocytes in blood have prognostic significance in idiopathic pulmonary fibrosis.
Liu YZ; Saito S; Morris GF; Miller CA; Li J; Lefante JJ
Genomics; 2019 Dec; 111(6):1343-1350. PubMed ID: 30261315
[TBL] [Abstract][Full Text] [Related]
11. Investigation of a Hypoxia-Immune-Related Microenvironment Gene Signature and Prediction Model for Idiopathic Pulmonary Fibrosis.
Li X; Cai H; Cai Y; Zhang Q; Ding Y; Zhuang Q
Front Immunol; 2021; 12():629854. PubMed ID: 34194423
[TBL] [Abstract][Full Text] [Related]
12. Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis.
Asai Y; Chiba H; Nishikiori H; Kamekura R; Yabe H; Kondo S; Miyajima S; Shigehara K; Ichimiya S; Takahashi H
Respir Res; 2019 Nov; 20(1):244. PubMed ID: 31694639
[TBL] [Abstract][Full Text] [Related]
13. High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis.
Bingham GC; Muehling LM; Li C; Huang Y; Ma SF; Abebayehu D; Noth I; Sun J; Woodfolk JA; Barker TH; Bonham CA
Front Immunol; 2023; 14():1308594. PubMed ID: 38292490
[TBL] [Abstract][Full Text] [Related]
14. Imbalanced distribution of regulatory T cells and Th17.1 cells in the peripheral blood and BALF of sarcoidosis patients: relationship to disease activity and the fibrotic radiographic phenotype.
Zhang H; Jiang D; Zhu L; Zhou G; Xie B; Cui Y; Costabel U; Dai H
Front Immunol; 2023; 14():1185443. PubMed ID: 37520566
[TBL] [Abstract][Full Text] [Related]
15. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
Front Immunol; 2022; 13():810338. PubMed ID: 35185901
[TBL] [Abstract][Full Text] [Related]
16. Immunological Similarities and Differences between Post-COVID-19 Lung Sequelae and Idiopathic Pulmonary Fibrosis.
Gangi S; Bergantini L; Cameli P; Paggi I; Spalletti M; Mezzasalma F; Bargagli E; d'Alessandro M
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540243
[TBL] [Abstract][Full Text] [Related]
17. Integrated plasma proteomics and lung transcriptomics reveal novel biomarkers in idiopathic pulmonary fibrosis.
Sivakumar P; Ammar R; Thompson JR; Luo Y; Streltsov D; Porteous M; McCoubrey C; Cantu E; Beers MF; Jarai G; Christie JD
Respir Res; 2021 Oct; 22(1):273. PubMed ID: 34689792
[TBL] [Abstract][Full Text] [Related]
18. Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients.
Galati D; De Martino M; Trotta A; Rea G; Bruzzese D; Cicchitto G; Stanziola AA; Napolitano M; Sanduzzi A; Bocchino M
Cytokine; 2014 Apr; 66(2):119-26. PubMed ID: 24418172
[TBL] [Abstract][Full Text] [Related]
19. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study.
Scott MKD; Quinn K; Li Q; Carroll R; Warsinske H; Vallania F; Chen S; Carns MA; Aren K; Sun J; Koloms K; Lee J; Baral J; Kropski J; Zhao H; Herzog E; Martinez FJ; Moore BB; Hinchcliff M; Denny J; Kaminski N; Herazo-Maya JD; Shah NH; Khatri P
Lancet Respir Med; 2019 Jun; 7(6):497-508. PubMed ID: 30935881
[TBL] [Abstract][Full Text] [Related]
20. Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis.
Lv J; Gao H; Ma J; Liu J; Tian Y; Yang C; Li M; Zhao Y; Li Z; Zhang X; Zhu Y; Zhang J; Wu L
Front Immunol; 2023; 14():1230266. PubMed ID: 37771586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
